Valrubicin

• Description :

  Valrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  723.64

• Molecular Formula :

  C34H32F3NO13

• Notes :

  Research use only, not for human use.

• Receptor :

  PKC

• CAS Number :

  56124-62-0